Treatment Of Hepatorenal Syndrome Stocks List
| Symbol | Grade | Name | % Change | |
|---|---|---|---|---|
| BIVI | D | BioVie Inc. | -7.44 | |
| CPIX | F | Cumberland Pharmaceuticals Inc. | -0.92 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Hepatorenal Syndrome stocks.
| Symbol | Grade | Name | Weight | |
|---|---|---|---|---|
| DFAC | A | Dimensional U.S. Core Equity 2 ETF | 0.0 | |
| VTI | A | Vanguard Total Stock Market ETF | 0.0 | |
| DFAT | A | Dimensional U.S. Targeted Value ETF | 0.0 | |
| DFAS | B | Dimensional U.S. Small Cap ETF | 0.0 | |
| VXF | A | Vanguard Extended Market ETF | 0.0 |
Compare ETFs
Related Industries:
Biotechnology
Drug Manufacturers - Specialty & Generic
- Treatment Of Hepatorenal Syndrome
Treatment of hepatorenal syndrome (HRS) is aimed at improving kidney function and preventing further damage to the kidneys. Treatment options may include medications to reduce the amount of fluid in the body, medications to reduce the amount of toxins in the blood, and dialysis. In some cases, a liver transplant may be necessary.
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles
